Azenta Inc (NASDAQ:AZTA) stock is trending lower in after-hours trading on Thursday, following the filing of a Form 3 with the U.S. Securities and Exchange Commission.
Form 3 Filing
Azenta Life Sciences, a life sciences tools company focused on enabling scientific organizations to bring therapies and breakthroughs to market faster, disclosed the filing.
According to the filing dated April 16, 2026, William E. Martin III, President of Multiomics at Azenta, submitted an initial statement of beneficial ownership under Section 16(a) of the Securities Exchange Act of 1934.
The filing indicates that no securities are beneficially owned.
Trading Metrics, Technical Analysis
Azenta Inc has a market capitalization of approximately $1.12 billion.
The stock has a 52-week high of $41.73 and a 52-week low of $19.87.
Price Action
According to Benzinga Pro data, AZTA closed the regular session at $24.32, up 3.68%, before falling to $21.00 in after-hours trading.
The stock was down 13.65% in after-hours trading.
Currently, the stock is positioned near the lower end of its 52-week range.
Benzinga’s Edge Stock Rankings show that Azenta is exhibiting a positive short-term price trend, while medium- and long-term trends remain negative.
Disclaimer: This content was produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Who is Danny on Shutterstock.com
Login to comment